Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
14022 ATTUNE Cementless RP Clinical Performance Evaluation
NCT02839850 · View on ClinicalTrials.gov ↗
Study Summary
The primary objective of this study is to examine the change from pre-operative baseline to two year postoperative functional performance improvement for the ATTUNE primary, cementless TKA RP system as measured with the KOOS questionnaire (KOOS-ADL sub-score). This will be carried out for two configurations: cruciate retaining rotating platform (ATTUNE Cementless CR RP) and posterior stabilized rotating platform (ATTUNE Cementless PS RP).
Conditions Studied
Interventions
- DEVICE Cementless Total Knee Arthroplasty
Study Locations (20)
Other
- Sevice de Chirurgie Orthoedique et Traumatologique — Salouël
- Klinikum Garmisch-Partenkirchen GmbH — Garmisch-Partenkirchen
- South Infirmary Victoria University Hospital — Cork
- University of Otago — Christchurch
- Nottingham University Hospitals NHS Trust — Nottingham
New Hampshire
- Dartmouth-Hitchcock Medical Center — Lebanon
- New London Hospital — New London
Colorado
- Colorado Joint Replacement — Denver
Florida
- Florida Research Associates — DeLand
New Jersey
- Rothman Institute — Egg Harbor
New York
- SUNY downstate Medical Center — Brooklyn
North Carolina
- UNC Chapel Hill — Chapel Hill
Tennessee
- Associated Orthopaedics of Kingsport — Kingsport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 540 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2027-09-01 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02839850
The ClinicalTrials.gov registry entry for NCT02839850 describes a study currently listed as active not recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 540 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DePuy Orthopaedics, which has 43 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Osteoarthritis appearing as the primary indexed condition, and to 1 intervention — of which Cementless Total Knee Arthroplasty is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT02839850 reports 20 study locations spanning 15 distinct geographic areas — top geographies include Other, New Hampshire, Colorado. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT02839850 about?
NCT02839850 is a clinical study titled "14022 ATTUNE Cementless RP Clinical Performance Evaluation". The primary objective of this study is to examine the change from pre-operative baseline to two year postoperative functional performance improvement for the ATTUNE primary, cementless TKA RP system as measured with the KOOS questionnaire (KOOS-ADL sub-score). This will be carried out for two config...
What is the current status of trial NCT02839850?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 540 participants. The study started on 2016-09-01. Estimated completion is 2027-09-01.
What conditions does trial NCT02839850 study?
This clinical trial studies the following conditions: Osteoarthritis. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT02839850?
The interventions under investigation include: Cementless Total Knee Arthroplasty (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT02839850?
This trial is sponsored by DePuy Orthopaedics, which has 43 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT02839850 being conducted?
This trial has 20 study locations across Colorado, Florida, New Hampshire, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.